A comprehensive overview of the molecular crosstalk between the Nrf2 and NLRP3 pathways in the pathogenesis of PD, with emphasis on how impaired Nrf2 signaling exacerbates NLRP3 inflammasome activation, is provided. Here, NFE2L2 is linked to Parkinson disease.